Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease (Q42232487)
Jump to navigation
Jump to search
scientific article published on 10 March 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease |
scientific article published on 10 March 2014 |
Statements
1 reference
Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease (English)
1 reference
Ju-Yeon Cho
1 reference
Yong-Han Paik
1 reference
Won Sohn
1 reference
Hyun Chin Cho
1 reference
Geum-Youn Gwak
1 reference
Moon Seok Choi
1 reference
Joon Hyeok Lee
1 reference
Kwang Cheol Koh
1 reference
Seung Woon Paik
1 reference
Byung Chul Yoo
1 reference
10 March 2014
1 reference
Identifiers
1 reference